Previous 10 | Next 10 |
Twist Bioscience Corp. (TWST) Q3 2021 Earnings Conference Call August 6, 2021, 8:00 AM ET Company Participants Emily Leproust – CEO and Co-Founder Angela Bitting – SVP of Corporate Affairs Jim Thorburn – CFO Conference Call Participants Doug Schenkel – Cowen Matt S...
Twist Bioscience (NASDAQ:TWST) reported second-quarter revenue that beat Wall Street estimates and raised its financial forecast for the year. Quarterly revenue increased 65% to $35.02M, beating analysts' average estimate by $2.59M. FY21 Guidance: revenue to be in the range of $129M-$132M ...
Twist Bioscience (NASDAQ:TWST) announces the appointment of Melissa Starovasnik to the company's board of directors. Starovasnik most recently served as Senior Scientific Advisor, Research at Genentech, and brings nearly three decades of experience in protein and antibody drug ...
Twist Bioscience (NASDAQ:TWST): Q3 GAAP EPS of -$0.82 misses by $0.07. Revenue of $35.02M (+65.1% Y/Y) beats by $2.59M. For the full fiscal year 2021, Twist provided the following updated financial guidance: Increasing revenue guidance, which is now expected to be in the range of $129 million...
-- Revenue Growth of 65% over Fiscal 2020 Third Quarter -- -- Order Growth of 58% Year over Year -- -- Gross Margin of 40% for the Quarter -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-qua...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it appointed Melissa Starovasnik, Ph.D. to its board of directors. Dr. Starovasnik most recently served as ...
AMCX, CGC, CNK, CRON, D, DKNG, ESNT, FLR, GT, IEP, LEA, MD, MGA, MGP, MMI, MODV, NCLH, NEO, NUAN, QRTEA, ROAD, SPB, SRCL, SSP, TWST, VNT, VTR For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Friday's open
Point Roberts, WA and Vancouver, BC - July 26, 2021 (Investorideas.com Newswire) Investorideas.com ( www.investorideas.com ), a global investor news source covering Artificial Intelligence (AI) brings you today's edition of The AI Eye - watching stock news, deal tracker and advancem...
Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and MOLCURE Inc., today announced they generated potent, binding antibodies to an undisclosed oncology target for Twist...
Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has started shipping its synthetic RNA reference controls for the SARS-CoV-2 Delta (B.1.617.2) and ...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...